Download PDF
Planta Med 2006; 72(1): 4-8
DOI: 10.1055/s-2005-873126
Original Paper
Pharmacology
© Georg Thieme Verlag KG Stuttgart · New York

Astragaloside IV from Astragalus membranaceus Shows Cardioprotection during Myocardial Ischemia in vivo and in vitro

Wei-Dong Zhang1 , 3 [*] , Hong Chen2 [*] , Chuan Zhang1 , Run-Hui Liu1 , Hui-Liang Li1 , Hong-Zhuan Chen2
  • 1Department of Natural Medicinal Chemistry, School of Pharmacy, Second Military Medical University, Shanghai, P. R. China
  • 2Department of Pharmacology, Shanghai Second Medical University, Shanghai, P. R. China
  • 3School of Pharmacy, Shanghai Jiao Tong University, Shanghai, P. R. China
Further Information

Publication History

Received: March 28, 2005

Accepted: May 27, 2005

Publication Date:
14 October 2005 (online)

Also available at
    Permissions and Reprints

Abstract

Astragaloside IV is the major active constituent of Astragalus membranaceus, which has been widely used for the treatment of cardiovascular diseases in China. However, the effects of astragaloside IV on myocardial ischemia and its mechanisms of action remain largely unknown. In this study, we have examined the effects of astragaloside IV on myocardial infarction and coronary flow in vivo and in vitro. The possible roles of its antioxidative and nitric oxide-inducing properties were also explored. Astragaloside IV significantly reduced infarct size in dogs subjected to coronary ligation in vivo. Astragaloside IV also improved post-ischemic heart function and ameliorated reperfusion arrhythmias in rat hearts in vitro. The cardioprotection of astragaloside IV was accompanied by a significant increase in coronary flow both in vivo and in vitro. The nitric oxide synthase inhibitor, Nω -nitro-L-arginine methyl ester partially abrogated astragaloside IV’s protective effect on heart function. Myocardial antioxidative enzyme superoxide dismutase activity increased with astragaloside IV administration. These data suggest the potential roles of antioxidative and nitric oxide-inducing properties of astragaloside IV in its protection from myocardial ischemia.

Key words

Astragaloside IV - ischemia - cardioprotection - nitric oxide - superoxide dismutase

References

  • 1 Li S Q, Yuan R X, Gao H, Wang Y Q. Clinical observation on treatment of ischemic heart disease with Astragalus membranaceus .  Chin J Integr Trad Western Med. 1995;  15 77-80
    PubMedSearch in Google Scholar
  • 2 Miller A L. Botanical influences on cardiovascular disease.  Altern Med Rev. 1998;  3 422-31
    PubMedSearch in Google Scholar
  • 3 Zhou S, Shao W, Wang W. Clinical study of Astragalus injection plus ligustrazine in protecting myocardial ischemia reperfusion injury.  Chin J Integr Trad Western Med. 2000;  20 504-7
    PubMedSearch in Google Scholar
  • 4 Sun C W, Lü W W, Lei C L, Wu Y, Chen Y. Effects of Astragalus saponins on experimental heart failure.  J N Berthune Univ Med School. 1994;  20 125-7
    PubMedSearch in Google Scholar
  • 5 Zhou J Y, Fan Y, Kong J L, Wu D Z, Hu Z B. Effects of components isolated from Astragalus membranaceus Bunge on cardiac function injured by myocardial ischemia reperfusion in rats.  China J Chin Mater Medica. 2000;  25 300-2
    PubMedSearch in Google Scholar
  • 6 Wang H K, He K, Ye J L. Chemical constituents of Astragalus mongholicus .  Chin Tradit Herb Drugs. 1987;  18 5-7
    PubMedSearch in Google Scholar
  • 7 Ji X, Tan B K, Zhu Y C, Linz W, Zhu Y Z. Comparison of cardioprotective effects using ramipril and DanShen for the treatment of acute myocardial infarction in rats.  Life Sci. 2003;  73 1413-26
    CrossrefPubMedSearch in Google Scholar
  • 8 Chen L B, Liu T, Wu J X, Chen X F, Wang L, Fan C L. et al . Hypertonic perfusion reduced myocardial injury during subsequent ischemia and reperfusion in normal and hypertensive rats.  Acta Pharmacol Sin. 2003;  24 1077-82
    PubMedSearch in Google Scholar
  • 9 Curtis M J, Walker M J. Quantification of arrhythmia using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia.  Cardiovasc Res. 1988;  22 656-65
    PubMedSearch in Google Scholar
  • 10 Shi G G, Chen J C, Li Z C, Liu X P. Direct effect of Astragalus membranaceus on coronary artery.  Trad Chin Drug Res Clin Pharmacol. 1999;  10 38-9
    PubMedSearch in Google Scholar
  • 11 Michel T, Feron O. Nitric oxide: which, where, how and why?.  J Clin Invest. 1997;  100 2146-52
    CrossrefPubMedSearch in Google Scholar
  • 12 Nathan C. Inducible nitric oxide synthase: what difference does it make?.  J Clin Invest. 1997;  100 2417-24
    PubMedSearch in Google Scholar
  • 13 Koboki K, Jiang Z Y, Takahara N, Ha S W, Igarashi M, Yamauchi T. et al . Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo .  Circulation. 2000;  101 676-81
    PubMedSearch in Google Scholar
  • 14 Wang P, Zweier J L. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart.  J Biol Chem. 1996;  271 29 223-30
    PubMedSearch in Google Scholar
  • 15 Ma X L, Weyrich A S, Lefer D J, Lefer A M. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium.  Circ Res. 1993;  72 403-12
    PubMedSearch in Google Scholar
  • 16 Rochetaing A, Kreher P. Reactive hyperemia during early reperfusion as a determinant of improved functional recovery in ischemic preconditioned rat hearts.  J Thorac Cardiovasc Surg. 2003;  125 1516-25
    CrossrefPubMedSearch in Google Scholar
  • 17 Beckman J S, Koppenol W H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad and ugly.  Am J Physiol. 1996;  271 C1424-C37
    PubMedSearch in Google Scholar
  • 18 Kobara M, Tatsumi T, Takeda M, Mano A, Yamanaka S, Shiraishi J. et al . The dual effects of nitric oxide synthase inhibitors on ischemia-reperfusion injury in rat hearts.  Basic Res Cardiol. 2003;  98 319-28
    CrossrefPubMedSearch in Google Scholar
  • 19 Narang D, Sood S, Thomas M K, Dinda A K, Maulik S K. Effect of dietary palm olein oil on oxidative stress associated with ischemic-reperfusion injury in isolated rat heart.  BMC Pharmacol. 2004;  4 29
    CrossrefPubMedSearch in Google Scholar
  • 20 Ostadal P, Elmoselhi A B, Zdobnicka I, Lukas A, Elimban V, Dhalla N S. Role of oxidative stress in ischemia-reperfusion-induced changes in Na+, K(+)-ATPase isoform expression in rat heart.  Antioxid Redox Signal. 2004;  6 914-23
    CrossrefPubMedSearch in Google Scholar
  • 21 Gupta S K, Mohanty I, Talwar K K, Dinda A, Joshi S, Bansal P. et al . Cardioprotection from ischemia and reperfusion injury by Withania somnifera: a hemodynamic, biochemical and histopathological assessment.  Mol Cell Biochem. 2004;  260 39-47
    CrossrefPubMedSearch in Google Scholar
  • 22 Ma Z, Yang Z. Scanvenging effects of Astragalus and Gynostemma pentaphyllum with its products on O2 - and OH.  J Chin Med Mat. 1999;  22 303-6
    PubMedSearch in Google Scholar
  • 23 Luo Y, Qin Z, Hong Z, Zhang X, Ding D, Fu J H. et al . Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia.  Neurosci Lett. 2004;  363 218-23
    CrossrefPubMedSearch in Google Scholar

1 The first two authors contribute equally to the work of this paper

Wei-Dong Zhang

Second Military Medical University

325 Guohe Rd.

Shanghai 200433

People’s Republic of China

Phone: +86-21-2507-0386

Fax: +86-21-6549-5819

Email: WDZhangY@hotmail.com